New England Pediatric Device Consortium (NEPDC) is pleased to announce four recipients of the organization’s latest round of seed awards.
Recipients of Pre-Seed funding and in-kind service support include PathMaker Neurosystems, a bioelectronics medicine company developing the MyoAmplifierTM system, an advanced non-invasive platform that treats children with paralysis and muscle weakness. Kobara Medical, a startup medical device company in Minnesota pioneering new transverse pericardial sinus (TPS) based cardiac rhythm management and neuromodulation procedures to address heart failure and cardiac arrhythmia, also received a Pre-Seed award.
In early January, EM Device Labs and Rx Bandz© received Full Seed Awards. These awards are a continuation of funding and support from NEPDC member organizations following a successful Pre-Seed engagement.
EM Device Labs has created the Quickloop, a novel abscess drainage device born out of the clinical need for a less invasive approach to painful abscess treatment in children. “We are honored to receive this award and excited to continue working with NEPDC”, says Dr. Michael Gorn, Chief Medical Officer for EM Device Labs and Assistant Clinical Professor of Pediatrics at the University of Texas Dell Medical School.
Rx Bandz© is an innovative and wearable next generation auto-injectable device for emergency medications. The wearable, human-centered design offers an attractive option to children and families living with life threatening allergies.
About New England Pediatric Device Consortium (NEPDC)
NEPDC is a non-profit consortium that provides infrastructure, expert consultation to innovators, and execution of technology translation and commercialization of pediatric technologies. NEPDC offers commercialization resources for pediatric medical devices through a seed grant program made possible through funds from the FDA Office of Orphan Product Development. For further information, visit www.NEPDC.org.